According to the latest report by IMARC Group, titled “United States Transfection Technologies Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” The United States transfection technologies market is expected to exhibit moderate growth during 2021-2026.
Transfection technology refers to the method of artificially introducing various nucleic acids, such as oligonucleotides, Deoxyribonucleic Acid (DNA), and Ribonucleic Acid (RNA), into the eukaryotic cells. It can be done using biological, physical, and chemical methods, which aid in modifying specific properties of the cell. Transfection includes electroporation, cationic lipid transfection, in-vivo transfection, etc. At present, it is extensively used for numerous genomic studies, including gene expression, RNA interference, screening, etc.
Request Free Sample Report: https://www.imarcgroup.com/united-states-transfection-technologies-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The elevating number of cases of infectious diseases that require antibiotics is driving the transfection technologies market in the United States. Additionally, the rising utilization of cell-based products is also augmenting the demand for transfection methods to treat various chronic diseases, such as tuberculosis, cardiovascular diseases, cancer, etc. Moreover, several reagent-based transfection technologies, including laserfection, biolistic technology, and microinjection, are gaining traction based on their accuracy and cost-effectiveness. Besides this, numerous manufacturers are focusing on extensive RD activities for advanced cytological studies, cancer therapeutics, and precision medicine, which are also fueling the market growth in the country. Apart from this, increasing investments by both private and government bodies to develop large-scale transfection facilities are further anticipated to bolster the United States market over the forecasted period.
United States Transfection Technologies Market 2021-2026 Analysis and Segmentation:
The report has segmented the market on the basis on region, product type, application, transfection method, technology, end user.
Breakup by Product Type:
Breakup by Application:
- Therapeutic Delivery
- Bio-Medical Research
- Protein Production
Breakup by Transfection Method:
- Cationic Lipid Transfection
- In-Vivo Transfection
Breakup by Technology:
- Physical Transfection
- Biochemical Based Transfection
- Viral-Vector Based Transfection
Breakup by End User:
- Research Centers and Academic Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Breakup by Region:
Ask Analyst for Customization and Explore Full Report with TOC List of Figure: https://www.imarcgroup.com/united-states-transfection-technologies-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800